Senzime has entered into an agreement to acquire the US company Respiratory Motion

Jul 26

Respiratory Motion, a med-tech company dedicated to the development of innovative devices to monitor respiratory variation, has entered into an agreement to be acquired by Senzime. To learn more, read the full news release.

Sondra Pierson

Senzime has entered into an agreement to acquire the US company Respiratory Motion

Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVID

Canada’s CFIA approves KnipBio Meal as a salmon feed ingredient